Investor · NORFOLK, VA

Jonathan Zalevsky

Open Jonathan in the network graph →

Filings

16

SEC Form D

Connections

85

co-filers

Capital

$24.0M

across filings

Active

Feb 2020

to Sep 2023

Most-connected co-filers (85)

Hao Sand Grove Capital Management LLP · London, United Kingdom6 shared John W. Ehli · NEW YORK, NY6 shared Chi H. Lee · Grand Cayman, Cayman Islands6 shared Bart N. Cocales · Seattle, WA6 shared Alex W. Schroder · RALEIGH, NC6 shared William R. Hazen · LARKSPUR, CA6 shared Matthew Kirk · San Rafael, CA6 shared Jennifer W. Collins · Grand Cayman, Cayman Islands6 shared Thomas Fleming · London, United Kingdom6 shared Aman Kant · Guilford, CT5 shared Stephen J. Doberstein · Guilford, CT4 shared Neil T. Wahlgren · Dallas, TX4 shared Sand Grove Opportunities Fund GP Ltd · Grand Cayman, Cayman Islands3 shared Michael J. Aiello · Guilford, CT3 shared Kerrie J. Brady · Guilford, CT3 shared Krishnan Nandabalan · Guilford, CT3 shared Salvatore J. Alesci · Guilford, CT3 shared Demetrios J. Kydonieus · Guilford, CT3 shared Shunichiro "Steve" J. Okada · Guilford, CT3 shared John Rickman · Norfolk, VA2 shared Peter Cheesbrough · DENVER, CO2 shared Neel Krishna · Norfolk, VA2 shared Lawrence Page · VANCOUVER, British Columbia, Canada2 shared Matthew J. Jill · New York, NY2 shared

Recent filings (16)

Invea Therapeutics, IncDec 2025 · 26 co-filers$120K Invea Therapeutics, IncDec 2025 · 26 co-filers$120K Sand Grove Opportunities Fund LtdSep 2025 · 10 co-filers Sand Grove Opportunities Fund LPSep 2025 · 12 co-filers Classover Holdings, Inc.Jun 2025 · 17 co-filers$500.0M Classover Holdings, Inc.Apr 2025 · 17 co-filers$5.0M Invea Therapeutics, IncApr 2025 · 26 co-filers$600K Invea Therapeutics, IncApr 2025 · 26 co-filers$600K Sand Grove Opportunities Fund LtdJun 2024 · 10 co-filers Sand Grove Opportunities Fund LPJun 2024 · 12 co-filers NEKTAR THERAPEUTICSMar 2024 · 17 co-filers$30.0M NEKTAR THERAPEUTICSMar 2024 · 17 co-filers$30.0M ReAlta Life Sciences, Inc.Sep 2023 · 28 co-filers$22.5M ReAlta Life Sciences, Inc.Sep 2023 · 28 co-filers$22.5M LabLabee Inc.Jul 2023 · 7 co-filers Sand Grove Opportunities Fund LtdJun 2023 · 10 co-filers Sand Grove Opportunities Fund LPJun 2023 · 12 co-filers LabLabee Inc.Jun 2023 · 7 co-filers Invea Therapeutics, IncApr 2022 · 19 co-filers$5.8M Invea Therapeutics, IncApr 2022 · 19 co-filers$5.8M ReAlta Life Sciences, Inc.Feb 2020 · 31 co-filers$2.0M ReAlta Life Sciences, Inc.Feb 2020 · 31 co-filers$2.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jonathan in the interactive graph →